Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.520
+0.010 (0.66%)
At close: Nov 14, 2025, 4:00 PM EST
1.500
-0.020 (-1.32%)
After-hours: Nov 14, 2025, 6:09 PM EST
Prelude Therapeutics Employees
Prelude Therapeutics had 131 employees as of December 31, 2024. The number of employees increased by 3 or 2.34% compared to the previous year.
Employees
131
Change (1Y)
3
Growth (1Y)
2.34%
Revenue / Employee
$80,153
Profits / Employee
-$853,221
Market Cap
115.72M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131 | 3 | 2.34% |
| Dec 31, 2023 | 128 | 6 | 4.92% |
| Dec 31, 2022 | 122 | 6 | 5.17% |
| Dec 31, 2021 | 116 | 48 | 70.59% |
| Dec 31, 2020 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PRLD News
- 1 day ago - Prelude Therapeutics Incorporated (PRLD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 days ago - PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation With the Schall Law Firm - Business Wire
- 10 days ago - Prelude Therapeutics Announces Strategic Business Update - GlobeNewsWire
- 10 days ago - Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors - GlobeNewsWire
- 11 days ago - Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting - GlobeNewsWire
- 4 weeks ago - Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors - GlobeNewsWire
- 3 months ago - Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire